Phreesia Shares Outstanding 2019-2025 | PHR
Phreesia shares outstanding from 2019 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Phreesia Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 58 |
| 2024 | 55 |
| 2023 | 52 |
| 2022 | 50 |
| 2021 | 40 |
| 2020 | 20 |
| 2019 | 2 |
| 2018 | 2 |
|
Phreesia Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-10-31 | 62 |
| 2025-07-31 | 62 |
| 2025-04-30 | 59 |
| 2025-01-31 | 58 |
| 2024-10-31 | 58 |
| 2024-07-31 | 58 |
| 2024-04-30 | 57 |
| 2024-01-31 | 55 |
| 2023-10-31 | 55 |
| 2023-07-31 | 54 |
| 2023-04-30 | 53 |
| 2023-01-31 | 52 |
| 2022-10-31 | 53 |
| 2022-07-31 | 52 |
| 2022-04-30 | 52 |
| 2022-01-31 | 50 |
| 2021-10-31 | 51 |
| 2021-07-31 | 51 |
| 2021-04-30 | 45 |
| 2021-01-31 | 40 |
| 2020-10-31 | 39 |
| 2020-07-31 | 38 |
| 2020-04-30 | 37 |
| 2020-01-31 | 20 |
| 2019-10-31 | 36 |
| 2019-07-31 | 7 |
| 2019-04-30 | 2 |
| 2019-01-31 | |
| 2018-10-31 | 2 |
| 2018-07-31 | 2 |
| 2018-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.988B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.527B | 42.25 |
| Tempus AI (TEM) | United States | $12.512B | 0.00 |
| Doximity (DOCS) | United States | $7.768B | 31.98 |
| Hims & Hers Health (HIMS) | United States | $7.144B | 58.11 |
| IRHYTHM HLDGS (IRTC) | United States | $5.386B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $3.165B | 0.00 |
| Privia Health (PRVA) | United States | $2.868B | 179.38 |
| Inspire Medical Systems (INSP) | United States | $2.680B | 44.34 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.267B | 46.35 |
| Azenta (AZTA) | United States | $1.840B | 75.47 |
| Enovis (ENOV) | United States | $1.371B | 7.20 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Schrodinger (SDGR) | United States | $1.237B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.051B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.868B | 0.00 |
| Talkspace (TALK) | United States | $0.656B | 132.00 |
| Standard BioTools (LAB) | United States | $0.600B | 0.00 |
| Claritev (CTEV) | United States | $0.503B | 0.00 |
| Evolent Health (EVH) | United States | $0.421B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.368B | 0.00 |
| Carlsmed (CARL) | United States | $0.334B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.317B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.28 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.182B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.096B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |